awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33397131-4AFA8B43-89FC-43EA-92BE-6326E480D697
Q33397131-4AFA8B43-89FC-43EA-92BE-6326E480D697
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397131-4AFA8B43-89FC-43EA-92BE-6326E480D697
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy.
P1433
Q33397131-4AFA8B43-89FC-43EA-92BE-6326E480D697
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397131-4AFA8B43-89FC-43EA-92BE-6326E480D697
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8a52baaf6bf2ff2e1ccbb54dc8f301578e0ce683
P1433
Cancer Chemotherapy and Pharmacology